Pablo Guardado-Calvo

Dr. Pablo Guardado-Calvo

Department of Virology, Institut Pasteur, 75015 Paris, France
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 January 2015 in Nature
Verified
Journal Article
Closed access
ARAlexander Rouvinski
Alexander Rouvinski
Pablo Guardado-CalvoPablo Guardado-Calvo
Pablo Guardado-Calvo
GBGiovanna Barba-Spaeth
Giovanna Barba-Spaeth
SDStéphane Duquerroy
Stéphane Duquerroy
MVMarie-Christine Vaney
Marie-Christine Vaney
FRFelix Rey
Felix Rey

21 November 2018 in Nature
Verified
Journal Article
Closed access
PDF file
RJRohit K Jangra
Rohit K Jangra
AHAndrew S. Herbert
Andrew S. Herbert
RLRong Li
Rong Li
LJLucas T. Jae
Lucas T. Jae
LKLara M. Kleinfelter
Lara M. Kleinfelter
KCKartik Chandran
Kartik Chandran

1 January 2017
Verified
Book Chapter
Closed access
Pablo Guardado-CalvoPablo Guardado-Calvo
Pablo Guardado-Calvo
FRFelix Rey
Felix Rey

20 February 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
JHJan Hellert
Jan Hellert
AAAndrea Aebischer
Andrea Aebischer
KWKerstin Wernike
Kerstin Wernike
AHAhmed Haouz
Ahmed Haouz
EBEmiliana Brocchi
Emiliana Brocchi
FRFelix Rey
Felix Rey
Orthobunyaviruses (OBVs) form a distinct genus of arthropod-borne bunyaviruses that can cause severe disease upon zoonotic transmission to humans. Antigenic drift or genome segment re-assortment have in the past resulted in new pathogenic OBVs, making them potential candidates for causing emerging zoonoses in the future. Low-resolution electron cryo-tomography studies have shown that OBV particles feature prominent trimeric spikes, but their molecular organization remained unknown. Here we report X-ray crystallography studies of four different OBVs showing that the spikes are formed by an N-terminal extension of the fusion glycoprotein Gc. Using Schmallenberg virus, a recently emerged OBV, we also show that the projecting spike is the major target of the neutralizing antibody response, and provide X-ray structures in complex with two protecting antibodies. We further show that immunization of mice with the spike domains elicits virtually sterilizing immunity, providing fundamental knowledge essential in the preparation for potential newly emerging OBV zoonoses.

15 September 2020 in Cell
Verified
Journal Article
Closed access
ASAlexandra Serris
Alexandra Serris
RSRobert Stass
Robert Stass
Eduardo Andres BignonEduardo Andres Bignon
Eduardo Andres Bignon
NMNicolas Alvaro Muena
Nicolas Alvaro Muena
JMJean-Claude Manuguerra
Jean-Claude Manuguerra
Pablo Guardado-CalvoPablo Guardado-Calvo
Pablo Guardado-Calvo

23 May 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
ARAlexander Rouvinski
Alexander Rouvinski
WDWanwisa Dejnirattisai
Wanwisa Dejnirattisai
Pablo Guardado-CalvoPablo Guardado-Calvo
Pablo Guardado-Calvo
MVMarie-Christine Vaney
Marie-Christine Vaney
ASArvind Sharma
Arvind Sharma
GSGavin R. Screaton
Gavin R. Screaton
A problem in the search for an efficient vaccine against dengue virus is the immunodominance of the fusion loop epitope (FLE), a segment of the envelope protein E that is buried at the interface of the E dimers coating mature viral particles. Anti-FLE antibodies are broadly cross-reactive but poorly neutralizing, displaying a strong infection enhancing potential. FLE exposure takes place via dynamic ‘breathing’ of E dimers at the virion surface. In contrast, antibodies targeting the E dimer epitope (EDE), readily exposed at the E dimer interface over the region of the conserved fusion loop, are very potent and broadly neutralizing. We here engineer E dimers locked by inter-subunit disulfide bonds, and show by X-ray crystallography and by binding to a panel of human antibodies that these engineered dimers do not expose the FLE, while retaining the EDE exposure. These locked dimers are strong immunogen candidates for a next-generation vaccine.